Boxer Capital as of March 31, 2023
Portfolio Holdings for Boxer Capital
Boxer Capital holds 75 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 10.0 | $204M | 1.9M | 107.32 | |
| Reata Pharmaceuticals Cl A | 5.5 | $112M | 1.2M | 90.92 | |
| BeiGene Sponsored Adr (ONC) | 5.3 | $108M | 500k | 215.53 | |
| Sarepta Therapeutics (SRPT) | 5.2 | $107M | 775k | 137.83 | |
| Apellis Pharmaceuticals (APLS) | 5.1 | $104M | 1.6M | 65.96 | |
| Tyra Biosciences (TYRA) | 5.1 | $104M | 6.4M | 16.07 | |
| Revolution Medicines (RVMD) | 5.0 | $102M | 4.7M | 21.66 | |
| Springworks Therapeutics (SWTX) | 4.3 | $88M | 3.4M | 25.74 | |
| Mirati Therapeutics | 3.7 | $74M | 2.0M | 37.18 | |
| Cytokinetics Com New (CYTK) | 3.6 | $74M | 2.1M | 35.19 | |
| Amylyx Pharmaceuticals (AMLX) | 3.0 | $61M | 2.1M | 29.34 | |
| Sage Therapeutics (SAGE) | 2.3 | $46M | 1.1M | 41.96 | |
| Seagen | 2.0 | $41M | 200k | 202.47 | |
| Relay Therapeutics (RLAY) | 1.8 | $36M | 2.2M | 16.47 | |
| Merus N V (MRUS) | 1.7 | $35M | 1.9M | 18.40 | |
| Viking Therapeutics (VKTX) | 1.6 | $33M | 2.0M | 16.65 | |
| 89bio (ETNB) | 1.6 | $32M | 2.1M | 15.23 | |
| Akero Therapeutics (AKRO) | 1.6 | $32M | 832k | 38.26 | |
| Nuvalent Inc-a (NUVL) | 1.6 | $32M | 1.2M | 26.09 | |
| Ideaya Biosciences (IDYA) | 1.5 | $30M | 2.2M | 13.73 | |
| Iteos Therapeutics | 1.4 | $29M | 2.2M | 13.61 | |
| Ventyx Biosciences (VTYX) | 1.4 | $29M | 850k | 33.50 | |
| Anaptysbio Inc Common (ANAB) | 1.4 | $28M | 1.3M | 21.76 | |
| Tango Therapeutics (TNGX) | 1.4 | $28M | 7.1M | 3.95 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $26M | 1.4M | 18.24 | |
| Amicus Therapeutics (FOLD) | 1.3 | $26M | 2.3M | 11.09 | |
| Rocket Pharmaceuticals (RCKT) | 1.2 | $25M | 1.5M | 17.13 | |
| Axsome Therapeutics (AXSM) | 1.2 | $25M | 400k | 61.68 | |
| Bellus Health Com New | 1.1 | $23M | 3.2M | 7.20 | |
| Iovance Biotherapeutics (IOVA) | 1.1 | $23M | 3.7M | 6.11 | |
| Exelixis (EXEL) | 1.1 | $22M | 1.2M | 19.41 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $22M | 600k | 35.79 | |
| Iveric Bio | 1.0 | $20M | 825k | 24.33 | |
| Rain Therapeutics | 0.9 | $19M | 2.1M | 8.74 | |
| Point Biopharma Global | 0.9 | $18M | 2.5M | 7.27 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $17M | 1.1M | 15.35 | |
| Day One Biopharmaceuticals I (DAWN) | 0.8 | $16M | 1.2M | 13.37 | |
| Enliven Therapeutics (ELVN) | 0.8 | $16M | 711k | 21.90 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $15M | 3.2M | 4.77 | |
| Prothena Corp SHS (PRTA) | 0.7 | $15M | 300k | 48.47 | |
| Kalvista Pharmaceuticals (KALV) | 0.6 | $13M | 1.7M | 7.86 | |
| Cullinan Oncology (CGEM) | 0.5 | $11M | 1.1M | 10.23 | |
| Nurix Therapeutics (NRIX) | 0.5 | $11M | 1.2M | 8.88 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 0.5 | $10M | 95k | 107.22 | |
| Morphic Hldg (MORF) | 0.4 | $7.5M | 200k | 37.64 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $6.0M | 1.1M | 5.70 | |
| Cogent Biosciences (COGT) | 0.3 | $5.7M | 525k | 10.79 | |
| Rapt Therapeutics | 0.3 | $5.5M | 300k | 18.35 | |
| Panacea Acquisition Corp II Cl A Shs | 0.3 | $5.1M | 500k | 10.22 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.2 | $4.9M | 250k | 19.57 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $4.8M | 1.3M | 3.85 | |
| 2Seventy Bio Common Stock | 0.2 | $4.7M | 460k | 10.20 | |
| Selecta Biosciences | 0.2 | $4.6M | 3.3M | 1.39 | |
| Cabaletta Bio (CABA) | 0.2 | $4.5M | 540k | 8.27 | |
| Gossamer Bio (GOSS) | 0.2 | $4.2M | 3.3M | 1.26 | |
| Prelude Therapeutics (PRLD) | 0.2 | $4.0M | 699k | 5.70 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $3.8M | 2.0M | 1.89 | |
| Kinnate Biopharma | 0.2 | $3.2M | 510k | 6.25 | |
| Theseus Pharmaceuticals | 0.2 | $3.1M | 350k | 8.88 | |
| Fate Therapeutics (FATE) | 0.1 | $2.9M | 500k | 5.70 | |
| Disc Medicine (IRON) | 0.1 | $2.8M | 130k | 21.19 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $2.8M | 699k | 3.94 | |
| Atreca Cl A Com (BCEL) | 0.1 | $2.5M | 2.2M | 1.14 | |
| DBV Technologies S A Sponsored Adr | 0.1 | $2.5M | 1.5M | 1.69 | |
| Third Harmonic Bio (THRD) | 0.1 | $2.4M | 570k | 4.12 | |
| Ngm Biopharmaceuticals | 0.1 | $2.0M | 500k | 4.08 | |
| Eqrx | 0.1 | $1.9M | 1.0M | 1.94 | |
| Bioatla (BCAB) | 0.1 | $1.8M | 686k | 2.68 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $1.6M | 2.3M | 0.71 | |
| ZIOPHARM Oncology | 0.0 | $945k | 1.5M | 0.63 | |
| MEI Pharma Com New | 0.0 | $667k | 2.9M | 0.23 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $655k | 209k | 3.13 | |
| Female Health (VERU) | 0.0 | $403k | 347k | 1.16 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $32k | 267k | 0.12 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $4.0k | 67k | 0.06 |